Cargando…

A Case Report of Olmesartan-Induced Enteropathy

Chronic olmesartan use can cause a drug-induced enteropathy as a rare side effect leading to diarrhea, significant weight loss, and reduced quality of life. The mechanism of this enteropathy is poorly understood and requires further investigation. We present a case of olmesartan-induced enteropathy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daines, Benjamin S, Kankam Jr., Alfred, Tanami, Sadia, Nambiar, Rajesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790005/ https://www.ncbi.nlm.nih.gov/pubmed/35106253 http://dx.doi.org/10.7759/cureus.20722

Ejemplares similares

Olmesartan-Induced Enteropathy: A Report of an Unusual Cause of Chronic Diarrhea
por: Sotiropoulos, Christos, et al.
Publicado: (2021)

A Rare Case of Olmesartan-Associated Enteropathy Successfully Managed With Steroid Taper
por: Xue, Angela, et al.
Publicado: (2023)

Olmesartan-Induced Enteropathy: A Case Report
por: Jadvani, Dharmikkumar, et al.
Publicado: (2023)

Rare Case of Olmesartan Induced Enteropathy
por: Handa, Richa, et al.
Publicado: (2017)

Enteropathy Associated with Olmesartan
por: Silva, Bruno Moreira da, et al.
Publicado: (2015)

Olmesartan-Induced Sprue Like Enteropathy
por: Carneiro, Liliana, et al.
Publicado: (2016)

Olmesartan-Induced Ischemic Enteritis Complicated With Bowel Perforation: A Case Report and Literature Review
por: Alexander, Dheeraj, et al.
Publicado: (2023)

Olmesartan-Induced Enteropathy: A Case of Recurrent Diarrhoea
por: Fernandes Matos, Ana Rita, et al.
Publicado: (2020)

Olmesartan-medoxomil: Sprue-like enteropathy: case report
Publicado: (2021)

Olmesartan‐induced enteropathy associated with cutaneous lesions
por: Hammoudi, Nassim, et al.
Publicado: (2016)

Olmesartan-associated Enteropathy Mimics Endoscopic Findings of Celiac Disease
por: Sasaki, Sho, et al.
Publicado: (2020)

Sprue-Like Enteropathy Associated with Olmesartan: An Unrecognized Emerging Drug-Induced Enteropathy?
por: Lourenço, Luís Carvalho, et al.
Publicado: (2016)

Olmesartan-induced Enteropathy Manifesting as Wernicke-Korsakoff Syndrome
por: Uehara, Takanori, et al.
Publicado: (2016)

Olmesartan-Induced Enteropathy: An Unusual Cause of Villous Atrophy
por: Eusébio, Marta, et al.
Publicado: (2015)

Prevalence of food-responsive enteropathy among dogs with chronic enteropathy in Japan
por: KAWANO, Koji, et al.
Publicado: (2016)

Sprue-Like Enteropathy Associated With Olmesartan: A New Kid on the Enteropathy Block
por: Hujoel, Isabel A., et al.
Publicado: (2016)

Spruelike Enteropathy Associated with Olmesartan: An Unusual Case of Severe Diarrhea
por: Dreifuss, Stephanie E., et al.
Publicado: (2013)

Protein-Losing Enteropathy in Crohn's Disease: Two Unusual Cases
por: Samant, Samira, et al.
Publicado: (2021)

Severe spruelike enteropathy and collagenous colitis caused by olmesartan
por: Kaneko, Shiho, et al.
Publicado: (2021)

Olmesartan Associated Sprue-Like Enteropathy and Colon Perforation
por: Abdelghany, Mahmoud, et al.
Publicado: (2014)

Gastrointestinal Disorder Associated with Olmesartan Mimics Autoimmune Enteropathy
por: Scialom, Sophie, et al.
Publicado: (2015)

Small bowel enteropathy associated with olmesartan medoxomil treatment
por: Galanopoulos, Michail, et al.
Publicado: (2017)

Olmesartan-Associated Enteropathy: An Unexpected Cause of Chronic Diarrhoea
por: Teixeira, Mónica, et al.
Publicado: (2019)

Olmesartan-Induced Spruelike Enteropathy: An Emerging Cause of Small Bowel Injury
por: Malik, Adnan, et al.
Publicado: (2020)

A Combination Therapy in a Rare Case of Adult-Onset Autoimmune Enteropathy
por: Amer, Bushra, et al.
Publicado: (2023)

Gallstone Enteropathy: An Unusual Cause of Bowel Obstruction
por: Matli, Venkata Vinod Kumar, et al.
Publicado: (2023)

Case of olmesartan-associated enteropathy and transient positive antitissue transglutaminase serology
por: Ghaith, Jenan, et al.
Publicado: (2018)

An Unusual Case of Enteropathy-associated T-cell Lymphoma Type 2 with Pulmonary Metastasis
por: Bhatlapenumarthi, Vineel, et al.
Publicado: (2019)

Olmesartan-induced Enteropathy: A Rare Side Effect of a Common Medication
por: Sher, Mustafa, et al.
Publicado: (2019)

Olmesartan-associated enteropathy: heterogeneity of involvement along gastrointestinal tract
por: Dias, Emanuel, et al.
Publicado: (2020)

Prognostic value of small intestinal dilatation in dogs with protein-losing enteropathy
por: OHTA, Hiroshi, et al.
Publicado: (2021)

A case report of olmesartan‐associated sprue‐like enteropathy: Diagnosis and healing confirmed by capsule endoscopy
por: Yamaguchi, Yoshiharu, et al.
Publicado: (2022)

Anti-N-Methyl-D-Aspartate Receptor Encephalitis Complicated by Autoimmune Enteropathy and Pulmonary Embolism: A Rare Case
por: Haider, Maryam B, et al.
Publicado: (2022)

Changes in the coagulation parameters in dogs with protein-losing enteropathy between before and after treatment
por: NAGAHARA, Takuro, et al.
Publicado: (2021)

A235 “WHAT’S SPRUE WITH YOU?”: OLMESARTAN-INDUCED ENTEROPATHY AS AN UNCOMMON MIMICKER OF CELIAC DISEASE
por: Milne, F, et al.
Publicado: (2023)

Sprue-Like Enteropathy and Liver Injury: A Rare Emerging Association with Olmesartan
por: Odak, Mihir, et al.
Publicado: (2021)

Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss
por: Gonakoti, Sripriya, et al.
Publicado: (2019)

Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study
por: You, Seng Chan, et al.
Publicado: (2019)

Expression of genes encoding inflammasome sensor subunits in the duodenal and colonic mucosae of dogs with chronic enteropathy
por: HIROKAWA, Marin, et al.
Publicado: (2021)

Expression of epithelial cell-derived cytokine genes in the duodenal and colonic mucosae of dogs with chronic enteropathy
por: OSADA, Hironari, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_853p9kqi5eq43jgr17r7crl2rn